Jonas Dorn is a data scientist, biologist, and engineer. He has been working on the development and implementation of digital biomarkers in clinical trials at major pharmaceutical companies for nearly 10 years. He has successfully deployed digital biomarker solutions in clinical trials across more than 10 different disease areas, and has been working with technologies including smartphone-based active monitoring, sensor-based passive monitoring, and virtual reality. He has co-authored multiple papers and patents on digital biomarkers, and has been featured on TV, radio, and in print media. Since 2020 he is a digital biomarker disease area lead at Roche, where he oversees digital biomarker development and deployment in multiple disease areas.
